Retatrutide, a experimental dual stimulator of the GLP-1 binding site and glucose-dependent insulinotropic polypeptide (GIP) receptor , is showing promising results in initial human studies. Ongoing https://topsocialplan.com/story7014620/retatrutide-emerging-studies-and-potential-medical-roles